RAGE processing in chronic airway conditions: Involvement of Staphylococcus aureus and ECP

Journal of Allergy and Clinical Immunology

Volumn 129, Issue 6, 2012, Pages 1515-1521.e8

  Van Crombruggen, Koen ^a   Holtappels, Gabriele ^a   De Ruyck, Natalie ^a   Derycke, Lara ^a   Tomassen, Peter ^a   Bachert, Claus ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

airway inflammation; eosinophil cationic protein; Receptor for advanced glycation end products; Staphylococcus aureus

Indexed keywords

ACETYLSALICYLIC ACID; ADAM10 ENDOPEPTIDASE; ADVANCED GLYCATION END PRODUCT RECEPTOR; EOSINOPHIL CATIONIC PROTEIN; GELATINASE B; INTERLEUKIN 5; MATRILYSIN; MEMBRANE BOUND RECEPTOR FOR ADVANCED GLYCATION END PRODUCT; MEMBRANE RECEPTOR; STROMELYSIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; ATOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RHINOSINUSITIS; CHRONIC RHINOSINUSITIS WITH NASAL POLYP; CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYP; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; STAPHYLOCOCCUS AUREUS; TISSUE HOMOGENATE;

EID: 84861705416     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.02.021     Document Type: Article

References (47)

1. C. Bopp, A. Bierhaus, S. Hofer, A. Bouchon, P.P. Nawroth, and E. Martin Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis Crit Care 12 2008 201
2. A. Raucci, S. Cugusi, A. Antonelli, S.M. Barabino, L. Monti, and A. Bierhaus A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10) FASEB J 22 2008 3716 3727
3. B.I. Hudson, A.M. Carter, E. Harja, A.Z. Kalea, M. Arriero, and H. Yang Identification, classification, and expression of RAGE gene splice variants FASEB J 22 2008 1572 1580
4. L. Zhang, M. Bukulin, E. Kojro, A. Roth, V.V. Metz, and F. Fahrenholz Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases J Biol Chem 283 2008 35507 35516
5. N. Yamakawa, T. Uchida, M.A. Matthay, and K. Makita Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells Am J Physiol Lung Cell Mol Physiol 300 2011 L516 L525
6. A. Bierhaus, P.M. Humpert, M. Morcos, T. Wendt, T. Chavakis, and B. Arnold Understanding RAGE, the receptor for advanced glycation end products J Mol Med 83 2005 876 886
7. Y. Wang, H. Wang, M.G. Piper, S. McMaken, X. Mo, and J. Opalek sRAGE induces human monocyte survival and differentiation J Immunol 185 2010 1822 1835
8. R. Pullerits, M. Brisslert, I.M. Jonsson, and A. Tarkowski Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1 Arthritis Rheum 54 2006 3898 3907
9. J.M. Englert, L.E. Hanford, N. Kaminski, J.M. Tobolewski, R.J. Tan, and C.L. Fattman A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis Am J Pathol 172 2008 583 591
10. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J Clin Invest 108 2001 949 955
11. A. Taguchi, D.C. Blood, T.G. del, A. Canet, D.C. Lee, and W. Qu Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases Nature 405 2000 354 360
12. J. Brett, A.M. Schmidt, S.D. Yan, Y.S. Zou, E. Weidman, and D. Pinsky Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues Am J Pathol 143 1993 1699 1712
13. N. Demling, C. Ehrhardt, M. Kasper, M. Laue, L. Knels, and E.P. Rieber Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells Cell Tissue Res 323 2006 475 488
14. M. He, H. Kubo, K. Ishizawa, A.E. Hegab, Y. Yamamoto, and H. Yamamoto The role of the receptor for advanced glycation end-products in lung fibrosis Am J Physiol Lung Cell Mol Physiol 293 2007 L1427 L1436
15. J.M. Englert, C.R. Kliment, L. Ramsgaard, P.S. Milutinovic, L. Crum, and J.M. Tobolewski Paradoxical function for the receptor for advanced glycation end products in mouse models of pulmonary fibrosis Int J Clin Exp Pathol 4 2011 241 254
16. L. Ramsgaard, J.M. Englert, J. Tobolewski, L. Tomai, C.L. Fattman, and A.S. Leme The role of the receptor for advanced glycation end-products in a murine model of silicosis PLoS One 5 2010 e9604
17. N. Ferhani, S. Letuve, A. Kozhich, O. Thibaudeau, M. Grandsaigne, and M. Maret Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease Am J Respir Crit Care Med 181 2010 917 927
18. S. Ohlmeier, W. Mazur, K. Salmenkivi, M. Myllarniemi, U. Bergmann, and V.L. Kinnula Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease Proteomics Clin Appl 4 2010 97 105
19. M.B. Sukkar, L.G. Wood, M. Tooze, J.L. Simpson, V.M. McDonald, and P.G. Gibson Soluble RAGE is deficient in neutrophilic asthma and COPD Eur Respir J 39 2012 721 729
20. C. Bachert, M. Wagenmann, U. Hauser, and C. Rudack IL-5 synthesis is upregulated in human nasal polyp tissue J Allergy Clin Immunol 99 1997 837 842
21. T. Van Zele, S. Claeys, P. Gevaert, M.G. Van, G. Holtappels, and C.P. van Differentiation of chronic sinus diseases by measurement of inflammatory mediators Allergy 61 2006 1280 1289
22. T. Van Zele, P. Gevaert, J.B. Watelet, G. Claeys, G. Holtappels, and C. Claeys Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis J Allergy Clin Immunol 114 2004 981 983
23. C. Bachert, N. Zhang, G. Holtappels, L.L. De, C.P. van, and S. Liu Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma J Allergy Clin Immunol 126 2010 962 968
24. C. Bachert, S.E. Claeys, P. Tomassen, Z.T. Van, and N. Zhang Rhinosinusitis and asthma: a link for asthma severity Curr Allergy Asthma Rep 10 2010 194 201
25. J.B. Watelet, C. Bachert, C. Claeys, and C.P. van Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis Allergy 59 2004 54 60
26. X. Li, J. Meng, X. Qiao, Y. Liu, F. Liu, and N. Zhang Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis J Allergy Clin Immunol 125 2010 1061 1068
27. K. Van Crombruggen, L. Van Nassauw, L. Derycke, J.P. Timmermans, G. Holtappels, and D. Hall Capsaicin-induced vasodilatation in human nasal vasculature is mediated by modulation of cyclooxygenase-2 activity and abrogated by sulprostone Naunyn Schmiedebergs Arch Pharmacol 383 2011 613 626
28. M.A. Hofmann, S. Drury, C. Fu, W. Qu, A. Taguchi, and Y. Lu RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901
29. L. Ramsgaard, J.M. Englert, M.L. Manni, P.S. Milutinovic, J. Gefter, and J. Tobolewski Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice PLoS One 6 2011 e20132
30. X. Su, M.R. Looney, N. Gupta, and M.A. Matthay Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury Am J Physiol Lung Cell Mol Physiol 297 2009 L1 L5
31. H. Zhang, S. Tasaka, Y. Shiraishi, K. Fukunaga, W. Yamada, and H. Seki Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury Am J Respir Crit Care Med 178 2008 356 362
32. M.A. Queisser, F.M. Kouri, M. Konigshoff, M. Wygrecka, U. Schubert, and O. Eickelberg Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types Am J Respir Cell Mol Biol 39 2008 337 345
33. L.E. Hanford, J.J. Enghild, Z. Valnickova, S.V. Petersen, L.M. Schaefer, and T.M. Schaefer Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE) J Biol Chem 279 2004 50019 50024
34. N. Van Bruaene, L. Derycke, C.A. Perez-Novo, P. Gevaert, G. Holtappels, and R.N. De TGF-beta signaling and collagen deposition in chronic rhinosinusitis J Allergy Clin Immunol 124 2009 253 259
35. P.W. Park, T.J. Foster, E. Nishi, S.J. Duncan, M. Klagsbrun, and Y. Chen Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus alpha-toxin and beta-toxin J Biol Chem 279 2004 251 258
36. A. Hayashida, A.H. Bartlett, T.J. Foster, and P.W. Park Staphylococcus aureus beta-toxin induces lung injury through syndecan-1 Am J Pathol 174 2009 509 518
37. T. Chavakis, A. Bierhaus, N. Al-Fakhri, D. Schneider, S. Witte, and T. Linn The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment J Exp Med 198 2003 1507 1515
38. B. Liliensiek, M.A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper, and S. Hofer Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J Clin Invest 113 2004 1641 1650
39. S.S. Yan, Z.Y. Wu, H.P. Zhang, G. Furtado, X. Chen, and S.F. Yan Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system Nat Med 9 2003 287 293
40. K. Nakamura, S. Yamagishi, H. Adachi, Y. Kurita-Nakamura, T. Matsui, and T. Yoshida Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes Mol Med 13 2007 185 189
41. C. Bopp, S. Hofer, J. Weitz, A. Bierhaus, P.P. Nawroth, and E. Martin sRAGE is elevated in septic patients and associated with patients outcome J Surg Res 147 2008 79 83
42. Y. Chen, E.M. Akirav, W. Chen, O. Henegariu, B. Moser, and D. Desai RAGE ligation affects T cell activation and controls T cell differentiation J Immunol 181 2008 4272 4278
43. W. Fokkens, V. Lund, and J. Mullol European position paper on rhinosinusitis and nasal polyps 2007 Rhinol Suppl 20 2007 1 136
44. M. Thomas, B.P. Yawn, D. Price, V. Lund, J. Mullol, and W. Fokkens EPOS primary care guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps 2 Prim Care Respir J 17 2008 79 89
45. E.O. Meltzer, D.L. Hamilos, J.A. Hadley, D.C. Lanza, B.F. Marple, and R.A. Nicklas Rhinosinusitis: establishing definitions for clinical research and patient care J Allergy Clin Immunol 114 2004 155 212
46. S. Sakurai, Y. Yamamoto, H. Tamei, H. Matsuki, K. Obata, and L. Hui Development of an ELISA for esRAGE and its application to type 1 diabetic patients Diabetes Res Clin Pract 73 2006 158 165
47. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT method Methods 25 2001 402 408